Glowing biosensor streamlines high-throughput drug screening
Drug discovery can be a long and complex process. Medicines for neurodegenerative diseases like Alzheimer's disease are among the most expensive to develop, as animal model results have not proven to be predictive of efficacy in humans. Scientists usually have to screen many biological targets before identifying a single potential new drug.
Drug discovery can be a long and complex process. Medicines for neurodegenerative diseases like Alzheimer's disease are among the most expensive to develop, as animal model results have not proven to be predictive of efficacy in humans. Scientists usually have to screen many biological targets before identifying a single potential new drug.
